Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5689321 | European Urology | 2017 | 7 Pages |
Abstract
We assessed how the incidence of ultimately fatal prostate cancer (PCa) changed over time. We found that the incidence of fatal PCa declined by >50% since the introduction of prostate-specific antigen testing and advances in treatment options; however, incidence rates among younger men remained relatively stable, and younger black men exhibited a 4.2-fold higher risk for fatal disease compared with white men.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Scott P. Kelly, Philip S. Rosenberg, William F. Anderson, Gabriella Andreotti, Naji Younes, Sean D. Cleary, Michael B. Cook,